Warning letter
Mentholatum Co. Inc.: warning letter of Apr 18, 2000
FDA warning letter UCM068352 · New York District Office
Key facts
| Reference number | UCM068352 |
|---|---|
| Company | Mentholatum Co. Inc. |
| Subject | Migraine Ice/Unpproved Application for Premarket Approval |
| Issue date | Apr 18, 2000 |
| Posted date | Apr 18, 2000 |
| Issuing office | New York District Office |
| Product type | Unknown |
| Country | 3 |
| Inspection city | Orchard Park |
| Inspection ZIP | 14127-1557 |
| Inspection start date | Oct 22, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: